Search - tctmd.com

Displaying 801 - 820 of 821

Sort: Relevancy | Date

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Industry News

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

February 02, 2011

News Daily News

Equivalent Stroke, Death Rates Achievable Between Carotid Stenting, Surgery

Jason Kahn

January 30, 2011

News Industry News

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

January 25, 2011

News Industry News

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

January 23, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Industry News

Boston Scientific to Acquire Atritech

January 18, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

January 09, 2011

News Industry News

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 09, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Caitlin E. Cox

January 06, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News Industry News

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

January 02, 2011

News

SYNTAX Published: CABG Remains Standard for Severe CAD

Caitlin E. Cox

February 18, 2009

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

CME

Advertisement

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

Equivalent Stroke, Death Rates Achievable Between Carotid Stenting, Surgery

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

Boston Scientific to Acquire Atritech

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Merck Statement on Changes to Clinical Studies of Vorapaxar

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

SYNTAX Published: CABG Remains Standard for Severe CAD

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content